JPMorgan U.S. Equity Fund
JUSRX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 277 Park Avenue New York NY United States of America 10172
- IPO Date
- May 15, 2006
- CIK
- 0001217286
- Website
- am.jpmorgan.com
- Similar Companies
- Business
- JPMorgan U.S. Equity Fund (JUSRX) is an open-end mutual fund managed by J.P. Morgan Asset Management that seeks high total return from a portfolio primarily invested in equity securities of large- and mid-capitalization U.S. companies, with up to 20% in foreign companies including depositary receipts; it employs fundamental analysis to construct a high-conviction, research-driven portfolio of approximately 50 stocks that closely mirrors the sector and risk factor exposures of the S&P 500 Index while differentiating through stock selection. The fund offers multiple share classes including R5 (JUSRX, net expense ratio 0.54%), I (JUESX), A (JUEAX), C (JUECX), L (JMUEX), R2 (JUEZX), R3 (JUEPX), R4 (JUEQX), and R6 (JUEMX), with total assets under management exceeding $35 billion as of late 2025. Core holdings as of September 2025 include NVIDIA Corp. (9.2%), Microsoft Corp. (8.8%), Apple Inc. (7.4%), Amazon.com Inc. (4.1%), and Alphabet Inc. Class A (4.0%), with top sectors comprising information technology (35.1%), financials (16.0%), and consumer discretionary (11.6%); the portfolio maintains a beta of 1.00, weighted average market cap of $1.44 trillion, and forward P/E ratio of 26.24. Led by portfolio manager Scott Davis (since 2014) and co-manager Shilpee Raina (since 2021), the strategy leverages a 20-member core analyst team whose compensation is partially tied to fund performance, emphasizing collaborative stock ranking, forward-looking risk assessment, and comparisons across correlated business characteristics rather than strict sector bets. The fund, part of J.P. Morgan Funds distributed by JPMorgan Distribution Services, Inc., operates within the large blend category and targets institutional and retirement investors with no minimum initial investment for R5 shares; it is domiciled in the United States with headquarters aligned to J.P. Morgan Asset Management in New York. Inception traces to a predecessor strategy launched in 1985, with the R5 share class commencing on May 15, 2006. In recent developments, the fund underwent portfolio adjustments in 2025, including selling out of UnitedHealth Group due to deteriorating outlook and shifting Broadcom from underweight to overweight amid reassessments by managers Davis and Raina, contributing to year-to-date underperformance versus the S&P 500 through mid-November 2025; these changes reflect ongoing scrutiny of non-held stocks and stock-specific risks like slumping NXP Semiconductors, which the team retains as undervalued. J.P. Morgan Asset Management maintained fee waivers through October 31, 2025, capping total annual operating expenses at 1.44% for certain classes, supporting net returns amid a growing asset base approaching $90 billion across the strategy. No major acquisitions, funding rounds, or structural reorganizations were reported in 2024-2025, with focus remaining on high-conviction U.S. large-cap equity execution.